Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria.
Neuropsychiatr. 2021 Sep;35(3):147-155. doi: 10.1007/s40211-021-00385-x. Epub 2021 Jan 28.
Visuo-Constructive functions have considerable potential for the early diagnosis and monitoring of disease progression in Alzheimer's disease.
Using the Vienna Visuo-Constructional Test 3.0 (VVT 3.0), we measured visuo-constructive functions in subjective cognitive decline (SCD), mild cognitive impairment (MCI), Alzheimer's disease (AD), and healthy controls to determine whether VVT performance can be used to distinguish these groups.
Data of 671 participants was analyzed comparing scores across diagnostic groups and exploring associations with relevant clinical variables. Predictive validity was assessed using Receiver Operator Characteristic curves and multinomial logistic regression analysis.
We found significant differences between AD and the other groups. Identification of cases suffering from visuo-constructive impairment was possible using VVT scores, but these did not permit classification into diagnostic subgroups.
In summary, VVT scores are useful indicators for visuo-constructive impairment but face challenges when attempting to discriminate between several diagnostic groups.
视空间建构功能在阿尔茨海默病的早期诊断和监测疾病进展方面具有很大的潜力。
使用维也纳视空间建构测验 3.0(VVT 3.0),我们测量了主观认知下降(SCD)、轻度认知障碍(MCI)、阿尔茨海默病(AD)和健康对照组的视空间建构功能,以确定 VVT 表现是否可用于区分这些组。
分析了 671 名参与者的数据,比较了诊断组之间的得分,并探讨了与相关临床变量的关联。使用接收者操作特征曲线和多项逻辑回归分析评估了预测的有效性。
我们发现 AD 与其他组之间存在显著差异。使用 VVT 评分可以识别出患有视空间建构障碍的病例,但这些评分不能将病例分类为诊断亚组。
总之,VVT 评分对视空间建构障碍是有用的指标,但在尝试区分几个诊断组时面临挑战。